Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis

NCT05045248 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Myasthenia Gravis
Ocular Myasthenia Gravis

Interventions

DRUG: Apraclonidine Hcl 0.5% Oph Soln

Sponsor

American University of Beirut Medical Center